Petros Pharmaceuticals PTPI
$ 0.25
0.12%
Quarterly report 2024-Q3
added 11-13-2024
Petros Pharmaceuticals Financial Ratios 2011-2024 | PTPI
Annual Financial Ratios Petros Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.4 | -0.2 | -0.2 | -1.6 | - | - | - | - | - | - | - | - | - |
P/S |
0.5 | 0.5 | 0.2 | 3.4 | - | - | - | - | - | - | - | - | - |
EPS |
-6.3 | -9.7 | -8.2 | -3.9 | - | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
11.1 M | 9.4 M | 9.5 M | 67.9 M | 50.3 M | - | - | - | - | - | - | - | - |
EBITDA per Share |
-4.75 | -6.92 | -10.3 | -1.09 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-1.7 | -2.1 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | -0.04 | - | - | - | - | - | - | - | - | - | ||
P/B |
0.2 | 0.2 | 0.0 | 1.9 | - | - | - | - | - | - | - | - | - |
P/CF |
-0.4 | -0.2 | -0.1 | -2.1 | - | - | - | - | - | - | - | - | - |
ROE % |
-67.63 | -119.97 | -25.28 | -117.84 | - | - | - | - | - | - | - | - | - |
ROA % |
-24.15 | -61.80 | -13.34 | -29.47 | - | - | - | - | - | - | - | - | - |
ROCE % |
-112.81 | -119.24 | -50.78 | -61.81 | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.6 | 2.1 | 2.1 | 0.6 | - | - | - | - | - | - | - | - | - |
DSO |
135.9 | 139.1 | 57.4 | 196.8 | - | - | - | - | - | - | - | - | - |
DIO |
383.2 | 186.1 | 59.3 | 68.6 | - | - | - | - | - | - | - | - | - |
DPO |
393.8 | 507.3 | 520.0 | 506.0 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
519.2 | 325.2 | 116.7 | 265.4 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
125.4 | -182.2 | -403.4 | -240.6 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Petros Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.53 | -0.37 | -1.69 | - | -2.85 | -1.2 | -0.66 | - | -6.69 | -0.88 | -0.08 | - | -0.17 | -0.22 | 0.31 | - | -0.96 | -1.68 | -3.45 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.16 | -0.21 | -0.67 | - | -1.88 | -0.77 | -0.23 | - | -5.86 | -0.05 | 0.52 | - | -0.19 | -0.26 | -0.05 | - | -0.2 | -0.98 | -2.13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-167.20 | -161.55 | -173.02 | -94.27 | -161.10 | -162.30 | -147.92 | -72.61 | -82.12 | -24.80 | -30.34 | -5.97 | -24.86 | -34.24 | 127.17 | 63.86 | 63.86 | 82.75 | -67.82 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-32.19 | -33.15 | -39.38 | -25.09 | -61.78 | -86.77 | -81.46 | -40.55 | -43.81 | -10.38 | -10.56 | -2.44 | -7.17 | -8.63 | -21.86 | -38.65 | -38.65 | -16.96 | -16.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-212.83 | -207.07 | -197.83 | -96.84 | -162.90 | -159.63 | -145.46 | -72.27 | -92.42 | -46.51 | -63.61 | -52.62 | -65.99 | -59.21 | 93.83 | 56.87 | 56.87 | 70.25 | -60.84 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.2 | 1.6 | 1.6 | 1.6 | 1.2 | 1.8 | 2.0 | 2.1 | 2.2 | 3.0 | 2.8 | 2.1 | 1.5 | 1.5 | 1.5 | 1.3 | 1.3 | - | 1.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
107.8 | 119.8 | 137.4 | - | 151.2 | 113.9 | 81.7 | - | 83.3 | 103.4 | 114.7 | - | 84.5 | 152.5 | 127.0 | - | 67.9 | 171.2 | 74.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
451.3 | 414.5 | 435.5 | - | 522.9 | 374.5 | 319.2 | - | 647.0 | 270.7 | 237.9 | - | 136.9 | 116.0 | 93.7 | - | 35.3 | 64.3 | 26.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
380.3 | 406.0 | 529.4 | - | 350.6 | 323.4 | 303.6 | - | 331.9 | - | 440.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
559.1 | 534.4 | 572.9 | - | 674.1 | 488.4 | 400.9 | - | 730.2 | 374.1 | 352.5 | - | 221.4 | 268.5 | 220.7 | - | 103.2 | 235.5 | 100.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
178.8 | 128.4 | 43.5 | - | 323.5 | 165.0 | 97.3 | - | 398.3 | 374.1 | -87.7 | - | 221.4 | 268.5 | 220.7 | - | 103.2 | 235.5 | 100.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency